Gene · 2192
Papers1,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhibition of antiapoptotic BCL-2 proteins with ABT-263 induces fibroblast apoptosis, reversing persistent pulmonary fibrosis. | JCI Insight | 2023 | 36752201 | PubTator, text mining | PubMed |
| Human and murine fibroblast single-cell transcriptomics reveals fibroblast clusters are differentially affected by ageing and serum cholesterol. | Cardiovasc Res | 2023 | 36718802 | PubTator, text mining | PubMed |
| Dysregulation of metalloproteins in ischemic heart disease patients with systolic dysfunction. | Int J Biol Macromol | 2023 | 36716834 | PubTator, text mining | PubMed |
| Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and Cholangiocarcinoma. | Cell Mol Gastroenterol Hepatol | 2023 | 36708970 | PubTator, text mining | PubMed |
| Mapping Multi-factor-mediated Chromatin Interactions to Assess Dysregulation of Lung Cancer-related Genes. | Genomics Proteomics Bioinformatics | 2023 | 36702236 | PubTator, text mining | PubMed |
| Stellate cell expression of SPARC-related modular calcium-binding protein 2 is associated with human non-alcoholic fatty liver disease severity. | JHEP Rep | 2023 | 36687468 | PubTator, text mining | PubMed |
| Clinical and Biological Significances of FBLN5 in Gastric Cancer. | Cancers (Basel) | 2023 | 36672502 | PubTator, text mining | PubMed |
| Advancements in Oncoproteomics Technologies: Treading toward Translation into Clinical Practice. | Proteomes | 2023 | 36648960 | PubTator, text mining | PubMed |
| The Need for Biomarkers in the ALS-FTD Spectrum: A Clinical Point of View on the Role of Proteomics. | Proteomes | 2023 | 36648959 | PubTator, text mining | PubMed |
Single-cell RNA sequencing reveals transcriptional changes of human choroidal and retinal pigment epithelium cells during fetal development, in healthy adult and intermediate age-related macular degeneration. | Hum Mol Genet | 2023 | 36645183 | PubTator, text mining | PubMed |
| TMT-based quantitative proteomic analysis reveals the underlying mechanisms of glycidyl methacrylate-induced 16HBE cell malignant transformation. | Toxicology | 2023 | 36641056 | PubTator, text mining | PubMed |
| Proteomics investigation of human sera for determination of postoperative indicators of pulmonary cystic echinococcosis. | J Cardiothorac Surg | 2023 | 36631795 | PubTator, text mining | PubMed |
| Transcriptional landscape of oncogene-induced senescence: a machine learning-based meta-analytic approach. | Ageing Res Rev | 2023 | 36621646 | PubTator, text mining | PubMed |
| Notch activation shifts the fate decision of senescent progenitors toward myofibrogenesis in human adipose tissue. | Aging Cell | 2023 | 36617688 | PubTator, text mining | PubMed |
| Silencing DTX3L Inhibits the Progression of Cervical Carcinoma by Regulating PI3K/AKT/mTOR Signaling Pathway. | Int J Mol Sci | 2023 | 36614304 | PubTator, text mining | PubMed |
Targeted and explorative profiling of kallikrein proteases and global proteome biology of pancreatic ductal adenocarcinoma, chronic pancreatitis, and normal pancreas highlights disease-specific proteome remodelling. | Neoplasia | 2023 | 36610378 | PubTator, text mining | PubMed |
| A network-guided protocol to discover susceptibility genes in genome-wide association studies using stability selection. | STAR Protoc | 2023 | 36609152 | PubTator, text mining | PubMed |
| Decellularized matrix for repairing intervertebral disc degeneration: Fabrication methods, applications and animal models. | Mater Today Bio | 2023 | 36590980 | PubTator, text mining | PubMed |
| Differential proteomic expression in indolent versus transforming oral lichen planus. | Exp Dermatol | 2023 | 36587284 | PubTator, text mining | PubMed |
| Proteomics separates adult-type diffuse high-grade gliomas in metabolic subgroups independent of 1p/19q codeletion and across IDH mutational status. | Cell Rep Med | 2023 | 36584682 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2192/papers?page=14